Drug intelligence / Profile preview

Oftal-Mycin

Development stage: Unknown
Modality: Small Molecules
Administration: Ophthalmic

Overview

Oftal-Mycin is an over-the-counter ophthalmic lubricant ointment containing light mineral oil and white petrolatum. It is used for temporary relief of burning, irritation, and discomfort due to dry eye or exposure to wind or sun, and can also serve as a protectant against further ocular irritation. The product acts through a **physical lubricating and barrier-forming mechanism** on the ocular surface rather than a specific receptor-mediated or enzyme-mediated pharmacologic target. The labeled product is associated with Grandall Distributing.

Brand names: Oftal-Mycin
Other names: Oftal-Mycin Lubricant Ophthalmic

Beyond the preview

Go deeper on Oftal-Mycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oftal-Mycin.

Explore the full profile